HE CHROMOSOMAL abnormalities frequently seen in human malignant cells are known to represent a crucial step in carcinogenesis. In lymphoid malignancies, the T-cell receptor (TCR) and Ig loci participate in many different translocations. These abnormalities mainly result in transcriptional activation of a presumptive oncogene on the partner chromosome, by juxtaposing regulatory elements of the TCRng genes. ' Many chromosome translocations present in various hematopoietic malignancies result in fusion genes encoding fusion proteins. The prototype of this situation is the fusion between the BCR and ABL genes in the t(9;22) of chronic myelogenous
The t(12;21) of Acute Lymphoblastic Leukemia Results in a tel-AML1 Gene Fusion
Analysis of a growing number of chromosomal translocations in human tumors have shown that they frequently result in gene fusions encoding chimeric proteins. We have characterized the recurrent t(12;21)(p12;q22) translocation present in human B-lineage acute leukemias. This translocation fused two genes, tel and AML1, that have previously been described in chromosomal translocations specific for myeloid malignancies. These two genes therefore belong to HE CHROMOSOMAL abnormalities frequently seen in human malignant cells are known to represent a crucial step in carcinogenesis. In lymphoid malignancies, the T-cell receptor (TCR) and Ig loci participate in many different translocations. These abnormalities mainly result in transcriptional activation of a presumptive oncogene on the partner chromosome, by juxtaposing regulatory elements of the TCRng genes. ' Many chromosome translocations present in various hematopoietic malignancies result in fusion genes encoding fusion proteins. The prototype of this situation is the fusion between the BCR and ABL genes in the t(9;22) of chronic myelogenous
Other important examples of translocation resulting in gene fusion have been documented in acute leukemias. Some translocations are specific for a given leukemic subtype, such as the t(1; 19) or the t( 15; 17),4,5 whereas other abnormalities are not so specific. This latter situation is typified by the I lq23 rearrangements, which are present in a variety of hematopoietic malignancies, ranging from lymphomas to various type of acute leukemias.6. ' Rearrangements of the chromosomal band 2Iq22, such as t(8;21) and t(3;21), have been shown to involve the AMLl gene and to be associated with myeloid rnalignan~ies.'.~ In these translocations, the chromosome 21 breakpoints are clustered within the 3' part of the AMLl locus.
We have recently identified a recurrent t(12;21)(p12;q22) in patients with B-cell lineage acute lymphoblastic leukemia (ALL), without detectable rearrangement of the "classical" AMLl breakpoint region." We now report the molecular an increasing number of human genes that are involved in a variety of hematopoietic malignant disorders and can be rearranged with numerous partners. Interestingly, in these acute leukemias, deletion of the other tel allele from the normal chromosome 12 was associated with the tel rearrangement, whereas both tel alleles were present in the chronic leukemias bearing a t(5;12) that we have tested. 0 1995 by The American Society of Hematology.
analysis of this translocation that nevertheless fuses the AMLl gene to the recently described ETS family gene, tel, involved in the t(5; 12)(q33;p13) translocation present in chronic myelomonocytic leukemia (CMML)."
MATERIALS AND METHODS

Patients and Cell Lines
Patient data are summarized in Table 1 . The cell lines used have been widely described. NB4 and HL60 are of myeloid origin. Raji is a Burkitt lymphoma cell line. RPM1 8226 is a myeloma cell line. An Epstein-Barr virus (EBV)-transformed lymphoblastoid cell line (JEF) was also used.
Fluorescent In Situ Hybridization (FISH)
FISH experiments were performed as described." YAC clones are from the CEPH library.
DNA and RNA Analysis
DNA was extracted by standard procedures." RNA was isolated after guanidine thiocyanate disruption of the cells followed by cesium chloride selection or phenol extraction." PolyA' RNA was prepared using oligo(dT) columns (Pharmacia, Les Ulis, France).
DNA samples (10 pg) were digested to completion with restriction enzymes and size-fractionated on 0.6% agarose gels. The denatured DNA was transferred to Hybond N (Amersham, Les Ulis, France).
Total RNA samples (10 pg) or poly A+ RNA (2 pg) were sizefractionated on 0.8% agaroselformaldehyde gels and transferred to Hybond N.
Hybridizations were performed in 0.5 m o m NaHzPOfla2HP04, 
Polymerase Chain Reaction (PCR) Experiments
Anchored PCR. Anchored PCR was performed using the ampli-FINDER RACE kit according to the manufacturer's instructions (Clontech, Palo Alto, CA), except that 500 ng of total RNA was reverse transcribed and the totality of the cDNA was used in subsequent steps. primers were as follows: B7 (CTGGACATllTCTCA-TAGGTC; nucleotides [nts]: 121 1-1 189 of the tel cDNA)" was used for reverse transcription; B8 (TGTITGTI'CTGTTCTTATGGT; nts 1146) were used in the h t and the second PCR, respectively.
Reverse transcriptase-PCR (RT-PCR).
Cell line cDNA was synthesized from 2.5 pg of total RNA using a cDNA Cycle kit (Invitrogen, San Diego, CA). One tenth of the reaction was submitted to PCR amplification in 50 pL with 0.4 pmol/L primers, 100 pmoY L of dNTPs, and 2.5 U of AmpliTaq (Cetus, Roissy, France) in the buffer recommended by the supplier. Patient RNA was treated similarly except that 0.25 pg of total RNA was retrotranscribed and 115 was submitted to PCR amplification. tel primers were B 11 (AACCTCTCTCATCGGGAAG, nts 937-955), B12 (CGTGGUTTCAAACAGTCCA; nts 876-895). B4 (GAGCGGTGCAACAGTIYAATATG; nts 549-569), F13 (GAG-ACATGTCTGAGACTCCT; nts 20-39), and F12 (GCGAAATGC-TGAATCAGCAG; nts 20-39, see Fig 4B) .
AMLl primers were AM1 (CATTGCCAGCCATCACAGTGAC; nts 1076-1097) and AM3 (AAGAGCTCGCTCATCTTGCCTGG; nts 833-855) of the AMLl cDNA.'~ Underlined nucleotides represent mutations introduced for cloning purposes.
1190-1169) and B9 (GG'ITTCCCCACAGTCGGACCA; nts 1171-
RESULTS
We recently described a recurrent translocation t(12;21) (p12;q22) in patients with B-cell ALL. Using YAC probes in FISH experiments, the chromosome 21 breakpoint was localized on bands 21q22.1q22.2, between the YACs 831B9 (proximal) and 745811 (distal). No direct involvement of the AMLl locus, which is localized on 21q22, could be documented by Southern blot analysis using a probe corresponding to the classical translocation breakpoint."
FISH Localizes the Breaboint Translocation on Chromosome 21
To localize the breakpoint more precisely, FISH experiments were performed on metaphases from leukemic cells (patients no. 1 and 2) with YAC clones spanning the region between YAC 745H11 and YAC 831B9, according to the chromosome 21 map.I7 In addition to the signal on the normal chromosome 21, hybridization with DNA from YAC clones 464H8 and 613E10 showed a signal on the der(l2) chromosome, whereas the signal generated with clone 72H9 localized to the der(21) (Fig 1) . Hybridization signal splitting was only seen with clone 812F11 (data not shown). Because of the telomere position of the 5 YAC clones relative to the LL103 Not I site," we deduced that the breakpoint of the t( 12;21) translocation mapped close to and probably telomeric to this site.
Molecular Cloning of the t(12;21) Translocation Breakpoint
The telomeric extremity of YAC clone 7289, estimated to be localized 20 to 30 kb telomeric to LL103 by pulsefield gel experiments (data not shown), was used to screen a phage genomic library established from patient no. l's DNA. A single clone was isolated that was shown to encompass the t( 12;21) chromosomal breakpoint by FISH experiments on metaphases of normal cells (data not shown). Repeat free fragments were used to isolate the normal counterparts of chromosome 12 from a genomic library established from normal DNA.
Analysis of additional overlapping genomic clones allowed us to deduce a restriction map of the surrounding chromosome 12 region (Fig 2) .
The tel Gene Is Rearranged by the t(12;21) Translocation
Phylogenetically conserved chromosome 12 probes, as determined by hybridizations on murine DNA, were then used to screen a cDNA library established from Raji cell line mRNA. One cDNA clone (SRI), when used as a probe in Northern blot experiments, detected three RNA species of approximately 7.8, 5.6, and 2.7 kb in Raji RNA (Fig 3A) . A similar hybridization pattern was evident in RPM1 8226. Only the two larger species were present in RNA extracted from a lymphoblastoid cell line. In the two myeloid cell lines tested (NB4 and HL60), only the 7.8-kb species was detectable. These data indicated the presence of a gene widely expressed within the hematopoietic system. Nucleotide sequence analysis of the SR1 cDNA clone showed identity with the published cDNA sequence of the tel gene, an ETS DNA binding domain transcription factor-encoding gene." Among additional cDNA clones isolated from the cDNA library, three were selected for further analysis because they showed different 5' extremities. One clone (SR13) was similar to the cDNA sequence described by Golub et al." In the second clone (SR15), 131 nucleotides were missing between nucleotide 57 and nucleotide 188, possibly because of exon skipping (Nucleotide numbering is according to Golub et all'). As a result, the first ATG was joined out of frame to the remaining 1 193 nucleotides of the tel coding sequence. In the third cDNA clone (SR12), a 223 nucleotide sequence was fused to nucleotide 188 (Fig 4B) . No in-frame ATG was contributed by this new sequence. Thus, for these two latter mRNA species, the translational use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From PCR experiments were performed on Raji and on NB4
cDNAs to confirm the expression of these variant tel mRNAs (see Materials and Methods). As shown in Fig 5, expression of the SRI3 type RNA is detected in both cell line cDNAs. By contrast, a specific fragment corresponding to the SR15 type is only barely seen, indicating that it represents a minor species. Gel analysis of RT-PCR experiments using SR12-specific primers showed multiple fragments migrating around the expected size of the SR12-amplified product (586 nucleotides). These data indicated the variability of the 5' side of the tel mRNAs. The mechanisms and consequences of this variability regarding the transcriptional and translational regulation remain to be determined. Southern experiments and partial nucleotide sequencing allowed us to determine the exon-intron organization of the tel gene in the translocation breakpoint region (Fig 2) . The orientation of tel transcription (from telomere to centromere) was deduced from FISH experiments using chromosome 12 phages on patient no. 2's metaphase cells (data not shown). Finally, the tel gene localization to 1 2~1 2 was performed by FISH to normal metaphase cells using phage 1 as a probe. in the ((5; 12) chromosomal translocation. We first investigated the status of the tel locus in four patients, two bearing t(12;21) and two (($12). A tel cDNA probe detected a rearranged BarnHI fragment in the four samples (data not shown). Single-copy genomic fragments were thus used to map the chromosome 12 breakpoints.
Probe B was used in Southern blot analysis of patients no. 1 and 2 (Fig 2, left panel) . In both cases, abnormal fragments were detected in EcoRI and BarnHI digests. The two t(12;21) breakpoints were thus clustered within a 5.5-kb EcoRI fragment, centromeric (3') to exon E. Surprisingly, germline fragments were absent from the DNA of the two patients (Fig 2, left panel) . This observation was confirmed by the use of other probes spanning the 20-kb BarnHI fragment, indicating that the other tel allele was at least partially deleted from the normal chromosome 12 in both patients. Particularly, exon E and ETS DNA binding encoding exon appeared to be deleted.
Southern blot analysis of patient no. 3's DNA using probe C (Fig 2, right panel) showed an abnormal pattern in addition to the germline pattern in EcoRI and Hind111 digests. The ((5; 12) breakpoint was localized within a 2-kb Hind111 fragment. This location telomeric (5') to exon E.is consistent with previous results." The breakpoint of the other ((5; 12) translocation (patient no. 13) was not precisely localized.
Taken together, these observations suggested that the tel locus might be particularly prone to rearrangements. These data prompted us to investigate the status of the tel locus in 9 patients (2 AML and 7 ALL) harboring various chromo- 
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nucleotide 784 of AMLl some 12 short arm abnormalities ( Table l ) . No gross abnormalities of this 20-kb BamHI fragment were detectable by Southern blotting using the described probes. In addition, the use of probe B, which detects a polymorphic EcoRI fragment, indicated the presence of both tel alleles in heterozygous patients (5/9; data not shown). Because a putative rearrangement could lie outside the analyzed region, we investigated the transcriptional status of the tel gene by Northem blotting when RNA was available (Fig 3B) . No transcriptional abnormality of the gene was detected in the samples tested, thus ruling out its direct involvement in these chromosome 12 abnormalities.
The Two Derivative Chromosomes Are Transcriptionally Active
Having localized the t( 12;21) breakpoint within the tel locus, we undertook to determine which derivative chromosome was transcribed in malignant cells. SRI cDNA was first used as a probe, because it started at nucleotide 1 198 of the cDNA and thus contained the ETS DNA binding domain but did not encompass the chromosome 12 breakpoint. No RNA from patient no. I was available. The Northern blot with RNA from patient no. 2 showed the presence of one major species of 6 kb (Fig 3B) , showing the transcription of the 3' side of the tel gene from der( 12) chromosome. Consistent with the Southem blot results, no normal expression of tel was detected in the RNA from patient no. 2.
To investigate the expression of the reciprocal derivative chromosome, the same membrane was probed with SR2 cDNA, which encompasses the breakpoint (Fig 3C) . In the lane corresponding to patient no. 2, an additional 8.4-kb abnormal mRNA was detected. Because the normal tel allele was not present, we concluded that this RNA was expressed from the der(21) and contains the 5' part of tel. 
Involvement of the AMLl Gene in the t(12;21)
To characterize putative chromosome 21 sequences fused 5' to the ETS DNA binding domain of tel, we performed anchored PCR starting with RNA from patient no. 2. After two rounds of PCR, amplified cDNAs were subcloned and 18 subclones were sequenced. Four were found to be germline tel cDNAs, certainly originated from normal cells present in the blood samples because these sequences (ie, exon E and the ETS DNA binding encoding exon) where shown by Southern blotting to be deleted from the nontranslocated chromosome 12 (see above). Eleven clones could be reconciled in a common sequence; the nucleotide sequence of the longest clone ( (34) is shown in Fig 4C. Three clones diverged from the G4 sequence upstream of nucleotide 121. The G4 sequence hybridized to human DNA within rodent cells hybrids containing human chromosome 21 (data not shown). This 232 nucleotide sequence contributed two in-frame ATGs with respect to the tel open reading frame (ORF). The sequence surrounding the first one was in good agreement with the consensus for translational initiation." However, the small size of the added ORF (19 amino acids) was intriguing and could correspond to the 5' part of a chromosome 21 gene. Because of the transcriptional orientation of G4 (telomere to centromere, similar to those of tel and AMLI) and the proximity to AMLI, we reasoned that it could represent an as yet uncharacterized 5' exon of AMLl.
To amplify a putative G4-AMLI transcript, primers specific for this new sequence and for AMLl were used in RT-PCR experiments. These G4-AMLI cDNAs could not be amplified from Raji cDNA. Otherwise, S' tel-AMLI 3' fused transcripts were amplified from patient cDNA using tel and various AMLI-specific primers. Southern blot analysis of PCR products with tel probes showed specific amplification when a tel primer (B12) was used together with several AMLl primers (see Materials and Methods) only in lanes corresponding to patient's cDNA but not to Raji cDNA. The identity of these fragments were confirmed by nucleotide sequence analysis to correspond to tel-AMLI cDNAs. Gel analysis of PCR experiments using B12 and AM3 primers is shown Fig 5B. The nucleotide sequence analysis of this PCR product is partially shown in Fig 4D. Consistent with the location of the chromosome 12 breakpoint, the fusion point between the two genes lay after nucleotide 1033 of tel. The tel sequences were linked to nucleotide 784 of AMLl by a 38 nucleotide intervening sequence. This sequence was likely to be an AMLI alternative S' exon because its partial sequence has been previously reported.2n This chimeric RNA could encode a protein consisting of the 336 amino acids with the NH2 side of tel fused to the entire AMLl protein.
In certain PCR products, skipping of the 38-bp putative exon led to direct fusion of tel to AMLl . The tel and AMLl ORFs were shifted in this species.
Two other fusion tel-AMLI cDNAs that resulted from the splicing of tel sequences to nucleotide 1038 of AMLI, either directly or via the 38-bp putative exon, were characterized (data not shown). These chimeric RNAs are out of frame and might represent minor splicing products. Nevertheless, we have shown that in-frame fusion tel-AML1 transcripts do exist.
DISCUSSION
We now report the molecular characterization of the t(12;21)(p12;q22), in two B-cell lineage ALLs. The translocation resulted in gene fusion between the tel gene on chromosome 12 and the AMLl gene on chromosome 21.
The tel gene has been recently isolated by virtue of its recombination with the PDGFRP gene following the ((5; 12)(q33;p13) translocation present in CMML." The predicted tel product exhibits a strong homology with the ETS DNA binding domain within its carboxy terminus. The ETS family members bind DNA in a site-specific fashion and are thought to act as transcriptional Like some other ETS DNA binding domain proteins, a predicted HLH motif lies at the amino terminus of tel that could be involved in protein-protein interaction that modulate transcriptional activation. 27 We have isolated several cDNA clones that differ in their 5' extremity, indicating that the tel gene could encode at least two protein species, both containing the ETS DNA binding domain but one lacking the NH2 part of the HLH motif. These isoforms could exhibit differential DNA binding or transactivating properties.
The gene located on chromosome 21 and involved in the t(12;21) was AMLI. The AMLl gene is the human equivalent of the gene encoding the a subunit of the core binding factor (CBF) also called P E B P~Q B .~~.~~ CBF, also known as PEBP2, is a multimeric proteic complex that binds to the core site in the enhancer of murine leukemia virus'"." and to similar core sequences in the enhancer of the polyomavi-IUS.~' It is present in multiple protein isoforrns, but functional analysis showed that the DNA-binding and heterodimerizing properties are localized within the runt homology domain of AMLI, whereas the transactivating domains lie further (Fig  2) . The chromosome 12 breakpoints of two t(12;21) were localized by Southern blot analysis, within the same intron of the tel gene, whereas the breakpoint of one t(5; 12) was mapped within the upstream adjoining intron. This latter localization is consistent with published data."
(2) In the t(5; 12), the 5' tel-PDGFRP 3' hybrid messenger is transcribed, whereas the reciprocal fusion transcript is not expressed. On the other hand, in the t(12;21), Northern blot analysis showed that both derivative chromosomes were transcriptionally active. Because tel is widely expressed, it is not surprising that the tel promoter(s) drives the expression of the fused 5' tel-AML1 3' transcript from the der(21) chromosome. The resulting hybrid product would contain all the putative transactivating motifs of the tel protein but lack the ETS DNA binding domain.
The ETS DNA binding domain is expressed from the reciprocal, der ( 12) (3) The normal allele of the tel gene was present in the two t(5; 12) patients analyzed, suggesting that the fusion gene product acts in a dominant fashion. By contrast, it was deleted from the normal chromosome 12 in both t(12;21) tested. Several explanations could account for this observation. This deletion could reflect the loss of a tumor-suppressor gene, potentially tel. Alternatively, the fusion products resulting from the t(12;21) could act in a recessive fashion and thus require the deletion of the normal tel allele. The action of both fusion products could necessitate the absence of the normal tel product. This absence would reinforce the action of the isolated ETS DNA binding domain in transcriptional regulation, particularly with regard to regulation of tel target genes. The action of the fused tel-AML1 product could also be impaired by the presence of the normal tel protein.
Golub et all' suggested that the amino terminal region of tel could exhibit dimerization capacities. According to this hypothesis, the product of tel could trap and somehow inactivate the fusion tel-AML1 protein.
Because tel was rearranged in at least two chromosomal abnormalities, we have investigated other 12p abnormalities present in acute leukemias (Table 1) . Despite the small size of our sample, our data do not support a high frequency of involvement of the tel gene in other 12p abnormalities.
The t(12;21) Differs From Other Translocations Involving AMLl
The AMLl gene localized on 21q22 is involved in two types of chromosomal translocations specific for myeloid rnalignancie~.~,' The t(8;21) is specific for AML type 2 and affects the putative transcription factor encoding gene, ETO, in some patients with chronic myelocytic leukemia in blast crisis (CML-BC), therapy-related myelodysplasic syndrome (t-MDS), or therapy-related acute myeloid leukemia (t-AML) and affects the EVIl locus at 3q26. EVIl encodes a zinc finger transcription factor and is also involved in other chromosome band 3q26 abnormalities.'"
In both translocations, the AMLl gene is disrupted 3' to the exons encoding the runt homology domain. The NH2 part of AML1, including the runt homology domain, is thus either fused to almost all the ET0 or the EVIl products or, in some cases, truncated because of an out-of-frame fuThe t(12;21) differs from other translocations involving AMLl by the location of the breakpoints within the AMLl locus and by the type of malignant proliferation. We have shown the involvement of the AMLl gene in the t( 12;21) by RT-PCR experiments. In the characterized tel-AML1 fused cDNAs, the fusion point is localized upstream of the t(8;21) fusion site, indicating that the chromosome 21 breakpoint lies at the 5' side of the AMLl gene. This location explains why the AMLl rearrangement was not previously detected, neither by FISH nor by Southern blotting experiments, using reagents designed to detect the classical AMLl rearrangements. However, because the genomic organization of AMLl is not known, the precise location of the chromosome 21 breakpoint with respect to the AMLl structure remains to be determinated. In this respect, the relationship between the G4 sequences and AMLl also needs to be investigated.
The tel promoter(s) drives the expression of fusion transcripts from the der 21 chromosome. Various tel-AML1 fusions were amplified from patient no. 2's cDNA. In-frame splicing of tel and AMLl occurs in a single species of telAMLl fusion mRNA, but our study was neither exhaustive nor fully representative of existing fusion mRNAs. The predicted hybrid protein includes the 336 amino terminal amino acids of tel, the region of ETS proteins that is thought to interact with other proteins, and almost all the AMLl product. Interestingly, ETS-1 and CBF were recently shown to cooperatively bind DNA within the T-cell receptor p enhancer.44 One can hypothesize that the hybrid tel-AML1 protein can be functionally equivalent and disregulate lymphoid-specific genes.
It should be emphasized that the tel gene is recombined with a tyrosine kinase receptor gene, PDGFXP, by the t(5; 12) in a chronic myeloid malignant proliferation and that no abnormal ETS DNA binding domain corresponding to tel appears to be expressed in these cells." In contrast, tel is fused to a transcription factor gene, AMLl, and an abnoron 8q22.8.9,16,38-40 The t(3;21)(q26;q22) has been described sion,20.42,43 use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From mal ETS motif might be present in ALL bearing the t( 12;21). Thus, the association of signal transmission deregulation with chronic leukemia and of transcription factor deregulation with acute leukemia follows the master gene hypothes i~:~ Further studies are needed to establish the respective contributions of the t(12;21) consequences (ie, tel disruption, tel-AML1 fusion, and expression of the sole ETS DNA binding domain) in leukemogenesis.
NOTE ADDED IN PROOF
The G4 and 5' AMLl 38 nucleotide exons have been described as part of a bona fide AMLl c D N A~~ (accession no. U19601). The sequences reported here have been submitted to EMBL (accession nos. 248355 
